Suzhou Basecare Medical Corporation Limited Stock
Equities
2170
CNE100004BC1
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.14 HKD | +6.47% | +9.74% | -8.94% |
Sales 2023 | 208M 28.71M 225M 39.17M | Sales 2024 * | 459M 63.3M 495M 86.36M | Capitalization | 495M 68.29M 534M 93.18M |
---|---|---|---|---|---|
Net income 2023 | -192M -26.5M -207M -36.16M | Net income 2024 * | -78M -10.77M -84.26M -14.69M | EV / Sales 2023 | 2.73 x |
Net cash position 2023 * | - 0 0 0 | Net cash position 2024 * | - 0 0 0 | EV / Sales 2024 * | 1.08 x |
P/E ratio 2023 |
-3.05
x | P/E ratio 2024 * |
-6.32
x | Employees | 586 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 26.54% |
1 day | +6.47% | ||
1 week | +9.74% | ||
Current month | +6.47% | ||
1 month | +10.88% | ||
3 months | -4.04% | ||
6 months | -22.74% | ||
Current year | -8.94% |
Managers | Title | Age | Since |
---|---|---|---|
Bo Liang
CEO | Chief Executive Officer | 44 | 10-12-13 |
Le Jun Yin
DFI | Director of Finance/CFO | 39 | 22-11-27 |
Mao She Rui
COO | Chief Operating Officer | 36 | 14-11-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xi Xiong Kang
BRD | Director/Board Member | 72 | 21-01-15 |
Bo Liang
CEO | Chief Executive Officer | 44 | 10-12-13 |
Ling Yin Kong
CTO | Chief Tech/Sci/R&D Officer | 44 | 11-06-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 2.14 | +6.47% | 184 500 |
24-04-26 | 2.01 | +0.50% | 31,500 |
24-04-25 | 2 | -1.48% | 13,200 |
24-04-24 | 2.03 | +1.50% | 6,000 |
24-04-23 | 2 | +2.56% | 30,500 |
Delayed Quote Hong Kong S.E., April 29, 2024 at 02:36 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.94% | 68.27M | |
-16.58% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-6.81% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B | |
-14.57% | 1.03B |
- Stock Market
- Equities
- 2170 Stock